LEO LUZNIK to Antibodies, Monoclonal, Murine-Derived
This is a "connection" page, showing publications LEO LUZNIK has written about Antibodies, Monoclonal, Murine-Derived.
Connection Strength
0.038
-
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas. Leuk Lymphoma. 2011 Nov; 52(11):2076-81.
Score: 0.020
-
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol. 2010 Jun; 21(6):1203-1210.
Score: 0.018